S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

JANX Janux Therapeutics Inc

66.25

3.82 (6.12%)

May 03 2024 - Closed

Delayed by 15 minutes

Janux Therapeutics closes $222.9M initial public offering

To read the full story on Seeking Alpha, click here.

Janux Therapeutics (NASDAQ:JANX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Janux Therapeutics Charts.

Janux Therapeutics (NASDAQ:JANX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Janux Therapeutics Charts.

Janux Therapeutics Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Friday 8 March 2024 (2 months ago) • Business Wire

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Thursday 29 February 2024 (2 months ago) • Business Wire

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Janux Therapeutics Announces Proposed Public Offering of Common Stock
Tuesday 27 February 2024 (2 months ago) • Business Wire

More Janux Therapeutics Inc News Articles

Umbra Applied Technologies (PK)

Bell Buckle (PK)

Code Green Apparel (PK)

Moon Equity (PK)

Marketing Worldwide (PK)

1812 Brewing (PK)

Cann American (CE)

Digital Brand Media and ... (PK)

Anavex Life Sciences

Intergrated Cannabis Sol... (PK)

Voip Pal Com (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions